Published in J Control Release on June 06, 2006
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
Stimuli-responsive theragrippers for chemomechanical controlled release. Angew Chem Int Ed Engl (2014) 0.95
Biomedical Imaging in Implantable Drug Delivery Systems. Curr Drug Targets (2015) 0.78
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Purification and properties of Drosophila heat shock activator protein. Science (1987) 4.60
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A (1994) 3.37
Epidemiological studies on patients with a persistent vegetative state. J Neurol Neurosurg Psychiatry (1977) 2.81
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J (1994) 2.81
'Ischemic tolerance' phenomenon found in the brain. Brain Res (1990) 2.73
Correlation between the induction of a gene for delta 1-pyrroline-5-carboxylate synthetase and the accumulation of proline in Arabidopsis thaliana under osmotic stress. Plant J (1995) 2.55
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng (2001) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia (1996) 2.22
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
FTZ-F1, a steroid hormone receptor-like protein implicated in the activation of fushi tarazu. Science (1991) 2.05
Dynamin GTPase domain mutants block endocytic vesicle formation at morphologically distinct stages. Mol Biol Cell (2001) 2.02
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med (1985) 1.81
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med (1997) 1.60
Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol (2001) 1.60
Physiologic consequences of positive end-expiratory pressure (PEEP) ventilation. Ann Surg (1973) 1.58
Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. Mol Cell Biol (1992) 1.57
Platycopia compacta n. sp., the Second Species of Platycopioida (Crustacea: Copepoda) in the Indo-Pacific Region, with Remarks on Development, Feeding, Swimming, and Zoogeography. Zoolog Sci (1998) 1.54
'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res (1991) 1.51
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med (2001) 1.49
Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care (1995) 1.46
Growth rate suppression of cultured mammalian cells enhances protein productivity. Cytotechnology (1994) 1.43
Repression of the Drosophila fushi tarazu (ftz) segmentation gene. EMBO J (1991) 1.43
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension. J Clin Invest (1967) 1.41
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination. J Antibiot (Tokyo) (1994) 1.41
A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus. Diabetologia (1995) 1.40
Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia (1993) 1.40
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler-Weber-Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Intern Med (1999) 1.39
Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1. J Biol Chem (1992) 1.38
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. Eur J Pharmacol (1997) 1.30
Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem (1998) 1.26
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR Am J Roentgenol (1999) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Analysis of the mRNA cap-binding ability of human eukaryotic initiation factor-4E by use of recombinant wild-type and mutant forms. Eur J Biochem (1996) 1.23
Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther (2005) 1.23
Temporally restricted expression of transcription factor betaFTZ-F1: significance for embryogenesis, molting and metamorphosis in Drosophila melanogaster. Development (2000) 1.22
Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience (2008) 1.21
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Yeast coactivator MBF1 mediates GCN4-dependent transcriptional activation. Mol Cell Biol (1998) 1.21
Overexpression of bcl-2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng (1995) 1.20
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Arrhythmogenic right ventricular dysplasia: evaluation with electron-beam CT. Radiology (1993) 1.17
Clinical observation of 52 cases of aortitis syndrome. Jpn Heart J (1969) 1.16
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
Dynamic structure of glomerular capillary loop as revealed by an in vivo cryotechnique. Virchows Arch (1996) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol (2000) 1.13
Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res (1998) 1.13
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage--immunohistochemical investigation of dendritic damage. Neuroscience (1989) 1.12
A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser. Nature (1979) 1.12
Distribution and responses of the cardiac sympathetic receptors to mechanically induced circulatory changes. Jpn Heart J (1969) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Intrathoracic neurogenic tumors: MR-pathologic correlation. AJR Am J Roentgenol (1992) 1.11
Growing new organs. Sci Am (1999) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Metastases to the penis from carcinoma of the prostate. Int J Urol (2001) 1.09
Piezoelectric and related properties of hydrated collagen. Biophys J (1976) 1.09
Surgical treatment of pulmonary aspergilloma and Aspergillus empyema. Ann Thorac Surg (1989) 1.08
Regulation of the EDG84A gene by FTZ-F1 during metamorphosis in Drosophila melanogaster. Mol Cell Biol (1996) 1.08
RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J Biol Chem (2000) 1.08
Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet (2000) 1.08
Observation on the mechanism of renin release by hydralazine in hypertensive patients. Circ Res (1970) 1.08
Multiprotein bridging factor 1 (MBF1) is an evolutionarily conserved transcriptional coactivator that connects a regulatory factor and TATA element-binding protein. Proc Natl Acad Sci U S A (1997) 1.07
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ (2008) 1.07
Mechanism of the reflex depressor effect by the kidney in dog. Jpn Heart J (1967) 1.06
Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J Clin Invest (1995) 1.06